{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T21:52:35Z","timestamp":1790632355557,"version":"4.1.0"},"reference-count":28,"publisher":"Scientific Scholar","issue":"1","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2024,1]]},"abstract":"\n Background & objectives:<\/jats:title>\n Iron deficiency anaemia (IDA) during pregnancy is treated with oral and parenteral iron. The objective of this review was to compare the clinical effectiveness, safety, pregnancy and neonatal outcomes of intravenous (iv) ferric carboxymaltose (FCM) and iv iron sucrose (IS) in treating IDA in pregnancy.<\/jats:p>\n <\/jats:sec>\n \n Methods:<\/jats:title>\n The Department of Health Research funded this study. PubMed, Cochrane Library, EMBASE and Scopus were searched to include studies published till November 2022. The protocol was registered in PROSPERO (CRD42022306092). Pregnant women (15-49 yr) in second and third trimesters, diagnosed with moderate-to-severe iron deficiency anaemia, treated with either of the drugs were included. The included studies were critically assessed using appropriate tools. We conducted a qualitative synthesis of the studies and meta-analysis for improvement in haematological parameters and incidence of adverse events.<\/jats:p>\n <\/jats:sec>\n \n Results:<\/jats:title>\n A total of 18 studies were included. The risk of bias was low to moderate. A rise in haemoglobin up to four weeks was higher with FCM than IS by 0.57 (0.24, 0.9) g\/dl. Intravenous FCM is associated with fewer adverse events than IS [pooled odds ratio: 0.5 (0.32, 0.79)]. The included studies had limited evidence on pregnancy and neonatal outcomes after iv iron treatment.<\/jats:p>\n <\/jats:sec>\n \n Interpretation & conclusions:<\/jats:title>\n Intravenous FCM is effective and safer than intravenous IS in terms of haematological parameters, in treating IDA in pregnancy. Further research is required on the effects of iv FCM and iv IS on the pregnancy and neonatal outcomes when used for treating IDA in pregnancy.<\/jats:p>\n <\/jats:sec>","DOI":"10.4103\/ijmr.ijmr_246_23","type":"journal-article","created":{"date-parts":[[2024,4,9]],"date-time":"2024-04-09T09:32:01Z","timestamp":1712655121000},"page":"62-70","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":12,"title":["Clinical effectiveness of ferric carboxymaltose (iv) versus iron sucrose (iv) in treatment of iron deficiency anaemia in pregnancy: A systematic review and meta-analysis"],"prefix":"10.25259","volume":"159","author":[{"given":"G.","family":"Srimathi","sequence":"first","affiliation":[{"name":"Department of Operational & Implementation Research, Mumbai, Maharashtra, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Revathy","sequence":"additional","affiliation":[{"name":"Department of Regional Resource Hub-Health Technology Assessment, ICMR - National Institute for Research in Reproductive & Child Health, Mumbai, Maharashtra, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bhavani Shankara","family":"Bagepally","sequence":"additional","affiliation":[{"name":"Division of Non Communicable Diseases, ICMR - National Institute of Epidemiology, Chennai, Tamil Nadu, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beena","family":"Joshi","sequence":"additional","affiliation":[{"name":"Department of Operational & Implementation Research, Mumbai, Maharashtra, India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10894","published-online":{"date-parts":[[2024,3,4]]},"reference":[{"key":"R4-20241212","doi-asserted-by":"crossref","first-page":"e572","DOI":"10.1016\/S2352-3026(21)00168-X","article-title":"Physiologically based serum ferritin thresholds for iron deficiency in children and non-pregnant women:A US National Health and Nutrition Examination Surveys (NHANES) serial cross-sectional study","volume":"8","author":"Mei","year":"2021","journal-title":"Lancet Haematol"},{"key":"R5-20241212","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1111\/j.1471-0528.1998.tb10120.x","article-title":"Anaemia in pregnancy in developing countries","volume":"105","author":"van den Broek","year":"1998","journal-title":"Br J Obstet Gynaecol"},{"key":"R7-20241212","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1186\/s12884-019-2200-3","article-title":"Comparison of ferric Carboxymaltose and iron sucrose complex for treatment of iron deficiency anemia in pregnancy- randomised controlled trial","volume":"19","author":"Jose","year":"2019","journal-title":"BMC Pregnancy Childbirth"},{"key":"R8-20241212","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1007\/s13224-022-01653-8","article-title":"A randomised controlled trial to compare injection ferric carboxymaltose and oral iron in treating iron deficiency anemia during pregnancy","volume":"72","author":"Chawla","year":"2022","journal-title":"J Obstet Gynaecol India"},{"key":"R9-20241212","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1111\/ajo.12695","article-title":"Safety and efficacy of intravenous iron polymaltose, iron sucrose and ferric carboxymaltose in pregnancy:A systematic review","volume":"58","author":"Qassim","year":"2018","journal-title":"Aust N Z J Obstet Gynaecol"},{"key":"R10-20241212","doi-asserted-by":"crossref","first-page":"e503","DOI":"10.1016\/S2352-3026(21)00137-X","article-title":"Iron (Fe) preparations for women of Reproductive age with Iron Deficiency Anaemia in pregnancy:FRIDA, a systematic review and network meta-analysis","volume":"8","author":"Rogozi\u0144ska","year":"2021","journal-title":"Lancet Haematol"},{"key":"R12-20241212","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1186\/s13643-019-1172-8","article-title":"Risk of bias tools in systematic reviews of health interventions:An analysis of PROSPERO-registered protocols","volume":"8","author":"Farrah","year":"2019","journal-title":"Syst Rev"},{"key":"R14-20241212","doi-asserted-by":"crossref","first-page":"e011458","DOI":"10.1136\/bmjopen-2016-011458","article-title":"Development of a Critical Appraisal Tool to Assess the Quality of Cross-Sectional studies (AXIS)","volume":"6","author":"Downes","year":"2016","journal-title":"BMJ Open"},{"key":"R16-20241212","doi-asserted-by":"crossref","DOI":"10.18203\/2320-1770.ijrcog20181933","article-title":"A comparative study of efficacy and safety of intravenous ferric carboxymaltose versus iron sucrose in the treatment of iron deficiency anaemia of pregnancy in a tertiary care hospital","volume":"7","author":"Mahajan","year":"2018","journal-title":"Int J Reprod Contracept Obstet Gynecol"},{"key":"R17-20241212","doi-asserted-by":"crossref","DOI":"10.18203\/2320-1770.ijrcog20192418","article-title":"A study for efficacy and safety of ferric carboxymaltose versus iron sucrose in iron deficiency anemia among pregnant women in tertiary care hospital","volume":"8","author":"Agrawal","year":"2019","journal-title":"Int J Reprod Contracept Obstet Gynecol"},{"key":"R18-20241212","first-page":"2154","article-title":"Pharmacotherapy in anaemia of pregnancy:Comparison of oral ferrous sulphate, intravenous iron sucrose","volume":"15","author":"Muhammad","year":"2021","journal-title":"PJMHS"},{"key":"R19-20241212","first-page":"195","article-title":"Comparative evaluation of efficacy, safety, cost effectiveness and acceptability of ferric carboxymaltose versus iron sucrose for treatment of iron deficiency anaemia in pregnancy:A multicenter open label randomized controlled trial","volume":"6","author":"Rahman","year":"2023","journal-title":"J Med Chem Sci"},{"key":"R20-20241212","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1515\/jpm-2011-0231","article-title":"Intravenous iron treatment in pregnancy:Comparison of high-dose ferric carboxymaltose versus iron sucrose","volume":"40","author":"Christoph","year":"2012","journal-title":"J Perinat Med"},{"key":"R21-20241212","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1002\/jppr.1265","article-title":"Intravenous iron sucrose and ferric carboxymaltose in pregnant patients:An observational study of maternal efficacy and tolerance","volume":"47","author":"Boughton","year":"2017","journal-title":"J Pharm Pract Res"},{"key":"R22-20241212","first-page":"4640635","article-title":"REGAIN STUDY:Retrospective study to assess the effectiveness, tolerability, and safety of ferric carboxymaltose in the management of iron deficiency anemia in pregnant women","author":"Wani","year":"2019","journal-title":"Anemia 2019"},{"key":"R23-20241212","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1186\/1471-2393-14-115","article-title":"Intravenous ferric carboxymaltose for anaemia in pregnancy","volume":"14","author":"Froessler","year":"2014","journal-title":"BMC Pregnancy Childbirth"},{"key":"R24-20241212","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1007\/s00404-018-4782-9","article-title":"Treatment of iron deficiency and iron deficiency anemia with intravenous ferric carboxymaltose in pregnancy","volume":"298","author":"Froessler","year":"2018","journal-title":"Arch Gynecol Obstet"},{"key":"R25-20241212","doi-asserted-by":"crossref","first-page":"3464","DOI":"10.1111\/jog.14956","article-title":"Clinical effects and safety of ferric carboxymaltose in pregnancy:An Indian real-life experience","volume":"47","author":"Gupte","year":"2021","journal-title":"J Obstet Gynaecol Res"},{"key":"R26-20241212","doi-asserted-by":"crossref","first-page":"54","DOI":"10.3329\/fmcj.v12i2.34228","article-title":"Intravenous iron treatment in pregnancy:Ferric carboxymaltose for correction of iron deficiency anaemia","volume":"12","author":"Zeba","year":"2017","journal-title":"Faridpur Med Coll J"},{"key":"R27-20241212","doi-asserted-by":"crossref","first-page":"324","DOI":"10.4103\/0970-258X.321145","article-title":"Intravenous ferric carboxymaltose rapidly increases haemoglobin and serum ferritin among pregnant females with moderate-to-severe anaemia:A single-arm, open-label trial","volume":"33","author":"Kant","year":"2020","journal-title":"Natl Med J India"},{"key":"R28-20241212","doi-asserted-by":"crossref","first-page":"96","DOI":"10.3126\/jnhrc.v15i2.18158","article-title":"Role of intravenous ferric carboxy-maltose in pregnant women with iron deficiency anaemia","volume":"15","author":"Mishra","year":"2017","journal-title":"J Nepal Health Res Counc"},{"key":"R29-20241212","first-page":"728952","article-title":"Safety and efficacy of ferric carboxymaltose in anemic pregnant women:A retrospective case control study","author":"Pels","year":"2015","journal-title":"Obstet Gynecol Int 2015"},{"key":"R30-20241212","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1007\/s00404-020-05817-7","article-title":"Comparison of the maternal and neonatal outcomes of pregnant women whose anemia was not corrected before delivery and pregnant women who were treated with intravenous iron in the third trimester","volume":"303","author":"Oskovi-Kaplan","year":"2021","journal-title":"Arch Gynecol Obstet"},{"key":"R31-20241212","first-page":"5060252","article-title":"Retrospective case reports of anemic pregnant women receiving intravenous ferric carboxymaltose:Experience from a tertiary hospital in Spain","author":"Aporta","year":"2016","journal-title":"Obstet Gynecol Int 2016"},{"key":"R32-20241212","first-page":"5759740","article-title":"Ferric carboxymaltose in the management of iron deficiency anemia in pregnancy:A subgroup analysis of a multicenter real-world study involving 1191 pregnant women","author":"Trivedi","year":"2022","journal-title":"Obstet Gynecol Int 2022"},{"key":"R33-20241212","doi-asserted-by":"crossref","first-page":"25","DOI":"10.4103\/2229-516X.149230","article-title":"Ferric carboxymaltose:A revolution in the treatment of postpartum anemia in Indian women","volume":"5","author":"Rathod","year":"2015","journal-title":"Int J Appl Basic Med Res"},{"key":"R35-20241212","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1007\/s00404-022-06768-x","article-title":"Intravenous ferric derisomaltose versus oral iron for persistent iron deficient pregnant women:A randomised controlled trial","volume":"308","author":"Hansen","year":"2023","journal-title":"Arch Gynecol Obstet"},{"key":"R36-20241212","doi-asserted-by":"crossref","first-page":"635","DOI":"10.5005\/jp-journals-10006-2080","article-title":"Role of iron isomaltoside 1000 in treatment of iron deficiency anemia in obstetrics and gynecological patients","volume":"14","author":"Aggarwal","year":"2023","journal-title":"J SAFOG"}],"container-title":["Indian Journal of Medical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.4103\/ijmr.ijmr_246_23","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,2]],"date-time":"2025-07-02T13:53:37Z","timestamp":1751464417000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.4103\/ijmr.ijmr_246_23"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1]]},"references-count":28,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.4103\/ijmr.ijmr_246_23","relation":{},"ISSN":["0971-5916","0975-9174"],"issn-type":[{"value":"0971-5916","type":"print"},{"value":"0975-9174","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,1]]},"assertion":[{"value":"2023-02-09","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}}]}}